Carrick Therapeutics
Edit

Carrick Therapeutics

http://www.carricktherapeutics.com/
Last activity: 18.05.2023
Categories: NewsLegalTechInformationBuilding
Carrick Therapeutics, transforming cancer treatments by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer
Mentions
19
Location: United States, Massachusetts, Boston
Total raised: $137.97M

Investors 5

Funding Rounds 2

DateSeriesAmountInvestors
01.12.2022Series C$42.97M-
04.10.2016-$95MGV

Mentions in press and media 19

DateTitleDescriptionSource
19.12.2022Carrick Therapeutics and the Menarini Group announce clinica...Carrick Therapeutics and the Menarini Group announce clinical trial collaboration to evaluate samura...cic.vc/new...
19.12.2022Carrick Therapeutics and The Menarini Group Announce Clinica...Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic b...en.prnasia...
02.12.2022Pfizer backs $60M infusion into Carrick, teams up on breast ...Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment Endpoints article | by...cic.vc/new...
01.12.2022Carrick Therapeutics Announces $35 Million Investment from P...-globenewsw...
17.08.2021Carrick Therapeutics to present first clinical data on Samur...Carrick Therapeutics to present first clinical data on Samuraciclib (CT-7001), a first-in-class inhi...cic.vc/new...
16.08.2021Carrick receives FDA Fast Track designations for two samurac...Carrick Therapeutics receives FDA Fast Track designations for two samuraciclib combinations for the ...cic.vc/new...
02.08.2021Carrick Therapeutics announces collaboration with RocheCarrick Therapeutics announces collaboration with Roche to evaluate novel Samuraciclib combination t...cic.vc/new...
11.10.2018Carrick Therapeutics in-licenses targeted ovarian cancer tre...- Exclusive worldwide licence deal adding to Carrick’s rapid pipeline expansion - Preparations for ...cic.vc/new...
30.11.2017First patient dosed in Carrick Therapeutics' phase 1 clinica...Carrick Therapeutics announces that the first patient has been dosed in the phase 1 clinical program...cic.vc/new...
09.10.2017Carrick Capital launches third fund, targets $400mSan Francisco-based Carrick Capital has launched a $400m third fund two years after closing its seco...altassets....
Show more

Reviews 0

Sign up to leave a review

Sign up Log In